Vis enkel innførsel

dc.contributor.authorLaakso, Saila
dc.contributor.authorHopolainen, Elina
dc.contributor.authorBetterle, Corrado
dc.contributor.authorSaari, Viivi
dc.contributor.authorVogt, Elinor Margrethe Chelsom
dc.contributor.authorSchmitt, Monica M
dc.contributor.authorWiner, Karen K.
dc.contributor.authorKareva, Maria A.
dc.contributor.authorSabbadin, Chiara
dc.contributor.authorHusebye, Eystein Sverre
dc.contributor.authorOrlova, Elizaveta
dc.contributor.authorLionakis, Michail
dc.contributor.authorMakitie, Outi
dc.date.accessioned2022-04-20T12:08:36Z
dc.date.available2022-04-20T12:08:36Z
dc.date.created2021-11-23T10:40:34Z
dc.date.issued2022
dc.identifier.issn0021-972X
dc.identifier.urihttps://hdl.handle.net/11250/2991633
dc.description.abstractContext Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED; also known as autoimmune polyendocrine syndrome type 1) has a severe, unpredictable course. Autoimmunity and disease components may affect fertility and predispose to maternal and fetal complications, but pregnancy outcomes remain unknown. Objective To assess fetal and maternal outcomes and course of clinical APECED manifestations during pregnancy in women with APECED. Design and Setting A multicenter registry-based study including 5 national patient cohorts. Patients 321 females with APECED. Main Outcome Measure Number of pregnancies, miscarriages, and deliveries. Results Forty-three patients had altogether 83 pregnancies at median age of 27 years (range, 17–39). Sixty (72%) pregnancies led to a delivery, including 2 stillbirths (2.4%) and 5 (6.0%) preterm livebirths. Miscarriages, induced abortions, and ectopic pregnancies were observed in 14 (17%), 8 (10%), and 1 (1.2%) pregnancies, respectively. Ovum donation resulted in 5 (6.0%) pregnancies. High maternal age, premature ovarian insufficiency, primary adrenal insufficiency, or hypoparathyroidism did not associate with miscarriages. Women with livebirth had, on average, 4 APECED manifestations (range 0-10); 78% had hypoparathyroidism, and 36% had primary adrenal insufficiency. APECED manifestations remained mostly stable during pregnancy, but in 1 case, development of primary adrenal insufficiency led to adrenal crisis and stillbirth. Birth weights were normal in >80% and apart from 1 neonatal death of a preterm baby, no serious perinatal complications occurred. Conclusions Outcome of pregnancy in women with APECED was generally favorable. However, APECED warrants careful maternal multidisciplinary follow-up from preconceptual care until puerperium.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titlePregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnanciesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1210/clinem/dgab705
dc.identifier.cristin1957641
dc.source.journalJournal of Clinical Endocrinology and Metabolism (JCEM)en_US
dc.source.pagenumbere528–e537en_US
dc.relation.projectStiftelsen Kristian Gerhard Jebsen: KGJ senter for autoimmune sykdommeren_US
dc.relation.projectNorges forskningsråd: 262677en_US
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism (JCEM). 2022, 107 (2), e528–e537en_US
dc.source.volume107en_US
dc.source.issue2en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal